Table 1.
Demographic and clinical characteristics of 36 patients with GBS in Aruba from 2003 to 2011
| N (%) | |
|---|---|
| Characteristics | |
| Age > 50 | 22 (61) |
| Men | 25 (69) |
| Preceding symptoms (≤ 4 weeks before GBS signs) | 23 (66) |
| Cranial nerve involvement | 11 (32) |
| Rapid onset of disease (bedridden within 4 days after onset of weakness) | 14 (39) |
| Severe maximum weakness | 28 (78) |
| Mechanical ventilation | 7 (19) |
| Mortality | 2 (6) |
| Long-term follow-up (> 6 months) | 18 (50) |
| Poor outcome (GBS disability score ≥ 3 after 6 months) | 10 (28) |
| Infections (not all patients tested) | |
| Campylobacter jejuni | 1/2 (50) |
| Dengue virus | 7/15 (47) |
| West Nile virus | 0/2 |
| Cytomegalovirus | 0/2 |
| Epstein–Barr virus | 0/2 |
| Mycoplasma pneumoniae | 0/2 |
GBS = Guillain–Barré syndrome.